Stockreport

What Does Wall Street Think About Beam Therapeutics (BEAM)? [Yahoo! Finance]

Beam Therapeutics Inc.  (BEAM) 
PDF Wainwright analyst Patrick Trucchio reiterated a Buy rating on Beam Therapeutics Inc. (NASDAQ:BEAM) on September 15, retaining the price target of $80. Is Beam Therape [Read more]